-- 
Elan Says Tysabri Patients Had Reduced Annualized Relapse Rates

-- B y   D a r a   D o y l e
-- 
2011-10-19T06:05:06Z

-- http://www.bloomberg.com/news/2011-10-19/elan-says-tysabri-patients-had-reduced-annualized-relapse-rates.html
Elan Corporation Plc said “key
data” indicated patients on Tysabri experienced reduced
annualized relapse rates, particularly in those treated early in
the course of their disease.  To contact the editor responsible for this story:
Dara Doyle at 
 ddoyle1@bloomberg.net  